Efficacy and safety of ablative techniques in elderly HCC patients

Annali Italiani di Chirurgia

Volumn 82, Issue 6, 2011, Pages 457-464

  Bove, Aldo ^a   Bongarzoni, Giuseppe ^a   Di Renzo, Raffaella M ^a   Marsili, Luca ^b   Chiarini, Stella ^a   Corbellini, Luciano ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Casa di Cura Spatocco ^*  (Italy)

Author keywords

HCC: hepatocellular carcinoma; RFA: radiofrequency thermal ablation; TACE: trans arterial chemo embolization

Indexed keywords

EID: 84855999142     PISSN: 2239253X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sherman Morris: Hepatocellular carcinoma: New and emerging risks. Digestive and Liver Disease, 2010; 42S: S215-22.
2. Lencioni Riccardo: Surveillance and early diagnosis of hepatocellular carcinoma. Digestive and Liver Disease, 2010; 42S: S223-27.
3. Asahina Yasuhiro, Tsuchiya Karou, Tamaki Nobuharu, et al: Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C Virus Infection. Hepatology, 2010; 52: 518-27.
4. Colombo M: Natural history of hepatocellular carcinoma. Ann Ital Chir, 2008; 79:91-97.
5. Poon RT, Fan ST, Tsang FH, Wong J: Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective. Ann Surg, 2002; 235:466-86.
6. Takahashi H, Mizuta T, Kawazoe S, et al: Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatology Research, 2010; 40:997-1005.
7. Mirici-Cappa F, Gramenzi A, Santi V et al: Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: A 20-year multicenter experience. Gut, 2010; 59:387-96.
8. Livraghi T: Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 2003; 10:67-76.
9. Xiao-Dong L, Li-Wu L: Local injection therapy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int, 2006.
10. Riaz A, et al: Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: Oncologic marker of radiologic response, progression and survival. Clin Oncol, 2009; 27 (34):5734-42.
11. Miraglia R, et al: Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for treatment of single hepatocellular carcinoma. World J Gastroenterol, 2007 June 7; 13 (21):2952-955.
12. Testa R, Testa E, Giannini E, et al: Trans-catheter arterial chemoembolization for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther, 2003; 17:1563-569.
13. Zhou Y, Zhao Y, Yang J, et al: Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterology, 2010; 10:78.
14. Curley SA, Izzo F: Radiorfequency ablation of hepatocellular carcinoma. Minerva Chir, 2002; 57 (2):165-76.
15. Bruix J, Sherman M, Llovet JM, et al: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. Journal of Hepatology, 2001; 35:421-30.
16. Schwartz M, Weintraub J: Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nat Clin Pract Oncol, 2008; 5 (11):630-31.
17. Bao-Quan C, Chong-Qi J, Chun-Tao L, et al: Chemoembolization combined with radiofrequency ablation for patient with hepatocellular carcinoma lager than 3 cm: A randomized controlled trial. JAMA, 2008; 229 (14):1669-677.
18. Wei-Zhu Y, et al: Combined therapy with trascatheter arterial chemoembilization and percutaneous microwave coaugulation for small hepatocellular carcinoma. World J Gastroenterol, 2009 February 14; 15 (6):748-52.
19. Kagawa T, Koizumi J, Mine T And The Tokai Rfa Study Group: Transcatheter arterial chemoembolisation plus radiofrequency ablation therapy for early stage of hepatocellular carcinoma. Cancer, 2010; 116:3638-44.
20. Sacco R, et al: Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: A cohort study. World J Gastroenterol, 2009; 15 (15):1843-48.
21. Whoo HY, Jang JW, Choi JY, et al: Tumour doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma. Scand J Gastroenterol, Epub ahead of print.
22. Yau T, Yao J, Tung Pin Poon R, et al: The outcome of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolisation. Cancer, 2009; 115:5507-15.
23. Dhanasekaran Renumathy, Khanna Vinit, Kooby David A, et al: The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. J Vasc Interv Radiol, 2010; 21:1197-204.
24. Mahady Suzanne E, Charlton Barbara, Fitzgerald Patrick, et al: Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage? Journal of Gastroenterology and Hepatology, 2010; 25:1299-305
25. Makuuchi M, Donadon M, Torzilli G: Hepatic resection for hepatocellular carcinoma in cirrhosis. Ann Ital Chir, 2008; 79:111-116.